IAPP and amyloidosis: Similarly, Koppel et al. highlighted the ability of CQDs to mitigate the catalytic effects of bacterial endotoxin LPS on Aβ and IAPP amyloidoses, positioning CQDs as potential anti-amyloidosis nanomedicines [21].